Overview
Rocky Mountain spotted fever (RMSF) is a tick-borne rickettsial infection characterized by fever, rash, and potential severe systemic complications including organ failure 14.Diagnosis
Clinical Presentation: Fever, headache, myalgia, and a characteristic rash (maculopapular, often starting centrally) 13.
Rash: Present in 10% of cases, often truncal initially 3.
Laboratory Findings: Elevated liver enzymes, thrombocytopenia, and leukopenia may occur 4.
Imaging: Chest radiographs may show interstitial or alveolar infiltrates, associated with higher mortality 5.
Tick Exposure History: Crucial for suspicion 3.
Serological Tests: Indirect immunofluorescence assay (IFA) for confirmation 1.
Skin Biopsy: May be performed but not routinely necessary 1.Management
First-Line Treatment: Chloramphenicol or doxycycline (adults and children >4 years) 14.
Dose: Chloramphenicol 100 mg/kg/day IV in 4 divided doses; doxycycline 100 mg PO twice daily for adults 4.
Duration: At least 5-7 days, extending based on clinical response 1.
Supportive Care: Includes fluid management, dialysis for renal failure, and monitoring for organ dysfunction 4.
Early Initiation: Critical to improve outcomes; delay can lead to high mortality 15.
Monitoring: Regular assessment of organ function, especially in severe cases 4.
Vaccine: Experimental vaccine produced from inactivated rickettsiae in chicken embryo cells shows promise 6.Special Populations
Pediatrics: Higher risk of fatal outcomes in children <10 years; early recognition crucial 1.
Comorbidities: RMSF should be considered in differential diagnosis for obscure febrile illnesses, even in non-endemic areas, particularly in immunocompromised or elderly patients 4.Key Recommendations
Suspect RMSF in patients with fever, rash, and tick exposure history, especially in endemic regions (Evidence: Moderate 3).
Initiate prompt treatment with doxycycline or chloramphenicol in suspected cases to reduce mortality (Evidence: Moderate 14).
Monitor for respiratory involvement via chest imaging, as it correlates with increased mortality (Evidence: Moderate 5).
Consider RMSF in differential diagnosis for severe febrile illnesses even outside endemic areas (Evidence: Weak 4).
Utilize rapid diagnostic tools like PEM-DXP for quick differential diagnosis in pediatric emergencies (Evidence: Expert opinion 3).References
1 Tull R, Ahn C, Daniel A, Yosipovitch G, Strowd LC. Retrospective Study of Rocky Mountain Spotted Fever in Children. Pediatric dermatology 2017. link
2 Sundy JS, Allen NB, Sexton DJ. Rocky Mountain spotted fever presenting with acute monarticular arthritis. Arthritis and rheumatism 1996. link
3 Simon JE. Computerized diagnostic referencing in pediatric emergency medicine. Pediatric clinics of North America 1992. link38412-7)
4 Lee SM. Viscerotropic Rocky Mountain spotted fever in southeastern Texas: report of a survivor with atypical manifestations and multiple organ failure. Southern medical journal 1989. link
5 Martin W, Choplin RH, Shertzer ME. The chest radiograph in Rocky Mountain spotted fever. AJR. American journal of roentgenology 1982. link
6 Kenyon RH, Pedersen CE. Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization. Journal of clinical microbiology 1975. link